BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 30187188)

  • 1. Co-Delivery of Teriflunomide and Methotrexate from Hydroxyapatite Nanoparticles for the Treatment of Rheumatoid Arthritis: In Vitro Characterization, Pharmacodynamic and Biochemical Investigations.
    Pandey S; Kumar V; Leekha A; Rai N; Ahmad FJ; Verma AK; Talegaonkar S
    Pharm Res; 2018 Sep; 35(11):201. PubMed ID: 30187188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyaluronate-functionalized hydroxyapatite nanoparticles laden with methotrexate and teriflunomide for the treatment of rheumatoid arthritis.
    Pandey S; Rai N; Mahtab A; Mittal D; Ahmad FJ; Sandal N; Neupane YR; Verma AK; Talegaonkar S
    Int J Biol Macromol; 2021 Feb; 171():502-513. PubMed ID: 33422513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and development of bioinspired calcium phosphate nanoparticles of MTX: pharmacodynamic and pharmacokinetic evaluation.
    Pandey S; Mahtab A; Kumar V; Jalees Ahmad F; Kamra Verma A; Talegaonkar S
    Drug Dev Ind Pharm; 2019 Jul; 45(7):1181-1192. PubMed ID: 30932720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Facile functionalization of Teriflunomide-loaded nanoliposomes with Chondroitin sulphate for the treatment of Rheumatoid arthritis.
    Mahtab A; Rabbani SA; Neupane YR; Pandey S; Ahmad A; Khan MA; Gupta N; Madaan A; Jaggi M; Sandal N; Rawat H; Aqil M; Talegaonkar S
    Carbohydr Polym; 2020 Dec; 250():116926. PubMed ID: 33049840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous inspired biomineral-installed hyaluronan nanoparticles as pH-responsive carrier of methotrexate for rheumatoid arthritis.
    Alam MM; Han HS; Sung S; Kang JH; Sa KH; Al Faruque H; Hong J; Nam EJ; Kim IS; Park JH; Kang YM
    J Control Release; 2017 Apr; 252():62-72. PubMed ID: 28288894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methotrexate Aspasomes Against Rheumatoid Arthritis: Optimized Hydrogel Loaded Liposomal Formulation with In Vivo Evaluation in Wistar Rats.
    Ghosh S; Mukherjee B; Chaudhuri S; Roy T; Mukherjee A; Sengupta S
    AAPS PharmSciTech; 2018 Apr; 19(3):1320-1336. PubMed ID: 29340978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylprednisolone acetate-loaded hydroxyapatite nanoparticles as a potential drug delivery system for treatment of rheumatoid arthritis: In vitro and in vivo evaluations.
    Jafari S; Maleki-Dizaji N; Barar J; Barzegar-Jalali M; Rameshrad M; Adibkia K
    Eur J Pharm Sci; 2016 Aug; 91():225-35. PubMed ID: 27189528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual-functional lipid polymeric hybrid pH-responsive nanoparticles decorated with cell penetrating peptide and folate for therapy against rheumatoid arthritis.
    Zhao J; Zhang X; Sun X; Zhao M; Yu C; Lee RJ; Sun F; Zhou Y; Li Y; Teng L
    Eur J Pharm Biopharm; 2018 Sep; 130():39-47. PubMed ID: 29928978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intra-articular drug delivery from an optimized topical patch containing teriflunomide and lornoxicam for rheumatoid arthritis treatment: does the topical patch really enhance a local treatment?
    Xi H; Cun D; Xiang R; Guan Y; Zhang Y; Li Y; Fang L
    J Control Release; 2013 Jul; 169(1-2):73-81. PubMed ID: 23567043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transdermal enhancement strategy of ketoprofen and teriflunomide: The effect of enhanced drug-drug intermolecular interaction by permeation enhancer on drug release of compound transdermal patch.
    Liu C; Guan Y; Tian Q; Shi X; Fang L
    Int J Pharm; 2019 Dec; 572():118800. PubMed ID: 31678378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanostructured lipid carriers engineered for intranasal delivery of teriflunomide in multiple sclerosis: optimization and in vivo studies.
    Gadhave DG; Kokare CR
    Drug Dev Ind Pharm; 2019 May; 45(5):839-851. PubMed ID: 30702966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-feruloylserotonin in preventive combination therapy with methotrexate reduced inflammation in adjuvant arthritis.
    Kuncirova V; Ponist S; Mihalova D; Drafi F; Nosal R; Acquaviva A; Gardi C; Harmatha J; Hradkova I; Bauerova K
    Fundam Clin Pharmacol; 2014 Dec; 28(6):616-26. PubMed ID: 24920394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Rheumatoid Arthritis by Serum Albumin Nanoparticles Coated with Mannose to Target Neutrophils.
    Lyu J; Wang L; Bai X; Du X; Wei J; Wang J; Lin Y; Chen Z; Liu Z; Wu J; Zhong Z
    ACS Appl Mater Interfaces; 2021 Jan; 13(1):266-276. PubMed ID: 33379867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced skin permeation of Methotrexate from penetration enhancer containing vesicles: In vitro optimization and in vivo evaluation.
    Sadarani B; Majumdar A; Paradkar S; Mathur A; Sachdev S; Mohanty B; Chaudhari P
    Biomed Pharmacother; 2019 Jun; 114():108770. PubMed ID: 30913494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of folate-conjugated glycol-chitosan nanoparticles in modulating the activated macrophages to ameliorate inflammatory arthritis: in vitro and in vivo activities.
    Kumar V; Leekha A; Kaul A; Mishra AK; Verma AK
    Drug Deliv Transl Res; 2020 Aug; 10(4):1057-1075. PubMed ID: 32363539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folate Conjugated Double Liposomes Bearing Prednisolone and Methotrexate for Targeting Rheumatoid Arthritis.
    Verma A; Jain A; Tiwari A; Saraf S; Panda PK; Agrawal GP; Jain SK
    Pharm Res; 2019 Jun; 36(8):123. PubMed ID: 31218557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the effect of andrographolide and methotrexate combined therapy in complete Freund's adjuvant induced arthritis with reduced hepatotoxicity.
    Li F; Li H; Luo S; Ran Y; Xie X; Wang Y; Zheng M; Wang M; Zhao Z; Li X
    Biomed Pharmacother; 2018 Oct; 106():637-645. PubMed ID: 29990853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation of a dual drug-loaded nanoparticulate co-delivery hydrogel system and its validation in rheumatoid arthritis animal model.
    Haloi P; Lokesh BS; Chawla S; Konkimalla VB
    Drug Deliv; 2023 Dec; 30(1):2184307. PubMed ID: 36852696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and evaluation of biopolymeric nanoparticles as drug delivery system in effective treatment of rheumatoid arthritis.
    Kumar V; Leekha A; Tyagi A; Kaul A; Mishra AK; Verma AK
    Pharm Res; 2017 Mar; 34(3):654-667. PubMed ID: 28097508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of nano lipid vesicles of methotrexate for anti-rheumatoid activity.
    Prabhu P; Shetty R; Koland M; Vijayanarayana K; Vijayalakshmi KK; Nairy MH; Nisha GS
    Int J Nanomedicine; 2012; 7():177-86. PubMed ID: 22275833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.